We studied the prevalence of tuberculin reactivity and anergy in 360 elderly patients residing in two municipal chronic disease hospitals. Eighty-five (26%) of the 323 patients tested had a positive reaction to a stage 1 tuberculin test and 12 (6%) of the 207 stage 1 tuberculin-negative patients exhibited a booster response to a stage 2 tuberculin test. Thirty percent of the same 207 patients had no response to an anergy panel of skin test antigens that included candida, mumps, and trichophyton. Nonresponders to tuberculin and the anergy panel had significantly higher one-year mortality rates compared to responders (44 v 20%, P = 0.001). Tuberculin-positivity among the 770 employees working in these facilities was 43%; 12 (4%) had a booster response. A survey of 29 randomly selected long-term care facilities in the Boston area indicated that all had a policy for pre-employment screening of employees, but less than 50% had a policy for patients and only one institution used two-stage testing. Routine tuberculin testing is recommended for long-term care facilities and the two-stage method is preferable in institutions with adequate resources.
Although mechanically ventilated patients represent only a small proportion of the hospital population at risk for pneumonia, they are generally seriously ill with disproportionately high rates of pneumonia and fatality. Hand carriage of nosocomial pathogens is a well-known mode of transmission and can be substantially reduced by proper handwashing. Knowledge of the potential hazards of all respiratory therapy equipment and tubing condensate is essential in preventing transmission of nosocomial pathogens that are often implicated in hospital-acquired pneumonia in ventilated patients. Administration of prophylactic antibiotics may reduce the risk of pneumonia, but more studies are needed in this area. Over the past decade there has been significant progress in the prevention of nosocomial pneumonia, but more research is needed to firmly establish the efficacy of these concepts in specific subsets of hospitalized patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.